Abingdon Health PLC
LSE:ABDX

Watchlist Manager
Abingdon Health PLC Logo
Abingdon Health PLC
LSE:ABDX
Watchlist
Price: 7.25 GBX Market Closed
Market Cap: 14m GBX
Have any thoughts about
Abingdon Health PLC?
Write Note

Intrinsic Value

ABDX doesn't have a meaningful market cap.

The intrinsic value of one ABDX stock under the Base Case scenario is 12.01 GBX. Compared to the current market price of 7.25 GBX, Abingdon Health PLC is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABDX Intrinsic Value
12.01 GBX
Undervaluation 40%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Abingdon Health PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ABDX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ABDX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Abingdon Health PLC

Provide an overview of the primary business activities
of Abingdon Health PLC.

What unique competitive advantages
does Abingdon Health PLC hold over its rivals?

What risks and challenges
does Abingdon Health PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Abingdon Health PLC.

Provide P/S
for Abingdon Health PLC.

Provide P/E
for Abingdon Health PLC.

Provide P/OCF
for Abingdon Health PLC.

Provide P/FCFE
for Abingdon Health PLC.

Provide P/B
for Abingdon Health PLC.

Provide EV/S
for Abingdon Health PLC.

Provide EV/GP
for Abingdon Health PLC.

Provide EV/EBITDA
for Abingdon Health PLC.

Provide EV/EBIT
for Abingdon Health PLC.

Provide EV/OCF
for Abingdon Health PLC.

Provide EV/FCFF
for Abingdon Health PLC.

Provide EV/IC
for Abingdon Health PLC.

Show me price targets
for Abingdon Health PLC made by professional analysts.

What are the Revenue projections
for Abingdon Health PLC?

How accurate were the past Revenue estimates
for Abingdon Health PLC?

What are the Net Income projections
for Abingdon Health PLC?

How accurate were the past Net Income estimates
for Abingdon Health PLC?

What are the EPS projections
for Abingdon Health PLC?

How accurate were the past EPS estimates
for Abingdon Health PLC?

What are the EBIT projections
for Abingdon Health PLC?

How accurate were the past EBIT estimates
for Abingdon Health PLC?

Compare the revenue forecasts
for Abingdon Health PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Abingdon Health PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Abingdon Health PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Abingdon Health PLC compared to its peers.

Compare the P/E ratios
of Abingdon Health PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Abingdon Health PLC with its peers.

Analyze the financial leverage
of Abingdon Health PLC compared to its main competitors.

Show all profitability ratios
for Abingdon Health PLC.

Provide ROE
for Abingdon Health PLC.

Provide ROA
for Abingdon Health PLC.

Provide ROIC
for Abingdon Health PLC.

Provide ROCE
for Abingdon Health PLC.

Provide Gross Margin
for Abingdon Health PLC.

Provide Operating Margin
for Abingdon Health PLC.

Provide Net Margin
for Abingdon Health PLC.

Provide FCF Margin
for Abingdon Health PLC.

Show all solvency ratios
for Abingdon Health PLC.

Provide D/E Ratio
for Abingdon Health PLC.

Provide D/A Ratio
for Abingdon Health PLC.

Provide Interest Coverage Ratio
for Abingdon Health PLC.

Provide Altman Z-Score Ratio
for Abingdon Health PLC.

Provide Quick Ratio
for Abingdon Health PLC.

Provide Current Ratio
for Abingdon Health PLC.

Provide Cash Ratio
for Abingdon Health PLC.

What is the historical Revenue growth
over the last 5 years for Abingdon Health PLC?

What is the historical Net Income growth
over the last 5 years for Abingdon Health PLC?

What is the current Free Cash Flow
of Abingdon Health PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Abingdon Health PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Abingdon Health PLC

Balance Sheet Decomposition
Abingdon Health PLC

Current Assets 3.8m
Cash & Short-Term Investments 2m
Receivables 1.3m
Other Current Assets 411k
Non-Current Assets 1.1m
Long-Term Investments 15k
PP&E 977k
Intangibles 76k
Current Liabilities 2.1m
Accounts Payable 2m
Other Current Liabilities 97k
Non-Current Liabilities 911k
Long-Term Debt 911k
Efficiency

Earnings Waterfall
Abingdon Health PLC

Revenue
5.3m GBP
Cost of Revenue
-2.3m GBP
Gross Profit
3.1m GBP
Operating Expenses
-5.6m GBP
Operating Income
-2.5m GBP
Other Expenses
306k GBP
Net Income
-2.2m GBP

Free Cash Flow Analysis
Abingdon Health PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ABDX Profitability Score
Profitability Due Diligence

Abingdon Health PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Declining ROE
Declining ROIC
17/100
Profitability
Score

Abingdon Health PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

ABDX Solvency Score
Solvency Due Diligence

Abingdon Health PLC's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
39/100
Solvency
Score

Abingdon Health PLC's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABDX Price Targets Summary
Abingdon Health PLC

There are no price targets for ABDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ABDX?

Click here to dive deeper.

Dividends

Abingdon Health PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for ABDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Abingdon Health PLC Logo
Abingdon Health PLC

Country

United Kingdom

Industry

Health Care

Market Cap

14m GBP

Dividend Yield

0%

Description

Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).

Contact

NORTH YORKSHIRE
York
York Biotech Campus, Sand Hutton
+44904406082.0
www.abingdonhealth.com

IPO

2020-12-15

Employees

151

Officers

Executive Chairman
Dr. Christopher William Hand
CEO, Company Secretary & Director
Mr. Chris Henry Francis Yates
Group Financial Controller
Laura Towse
Chief Operating Officer
Mr. Mark Jones

See Also

Discover More
What is the Intrinsic Value of one ABDX stock?

The intrinsic value of one ABDX stock under the Base Case scenario is 12.01 GBX.

Is ABDX stock undervalued or overvalued?

Compared to the current market price of 7.25 GBX, Abingdon Health PLC is Undervalued by 40%.

Back to Top